Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 3790 | Other Identifier | OUHSC IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators hypothesis is that there will be improvement in FEV1 in patients with severe asthma. This is a retrospective data study that reviews preexisting medical records; no patients will be enrolled.
The investigators plan is to retrospectively evaluate spirometry on patients with severe asthma who have undergone bronchial thermoplasty. The procedure will have been done according to the recommended protocol of three separate sessions. For each patient all available spirometric data obtained before and after thermoplasty will be used. Data will be collected from two centers, OU Medical Center and St. Francis Hospital in Tulsa, OK. All procedures done at St. Francis have been performed by a single physician and he is providing their spirometric data for the investigators study. The following data will be collected for all participants undergoing bronchial thermoplasty: Age, height, sex, weight, medical history, smoking history, baseline spirometry before and after bronchodilators, post thermoplasty spirometry before and after bronchodilators.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Past Bronchial Thermoplasty data | Data will be collected from records of patients who, in the past, have undergone bronchial thermoplasty. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The primary endpoints are improvements in prebronchodilator FEV1 and FVC. | The primary endpoints are improvements in prebronchodilator FEV1 and FVC by 12% predicted. | 1 year after thermoplasty |
| Measure | Description | Time Frame |
|---|---|---|
| Secondary endpoints are improvements in postbronchodilator FEV1 and FVC and degree of bronchodilator responsiveness. | Secondary endpoints are improvements in postbronchodilator FEV1 and FVC and degree of bronchodilator responsiveness by 12% predicted. | 1 year after thermoplasty |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Retrospective review of Asthma Patients' records
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Brent Brown, MD | Contact | 405-271-6173 | brent-brown@ouhsc.edu | |
| Clinical Trials Manager | Contact | research@ouhsc.edu |
| Name | Affiliation | Role |
|---|---|---|
| Brent Brown, MD | OUHSC | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| OUHSC | Recruiting | Oklahoma City | Oklahoma | 73104 | United States |
Deidentified data may only be shared upon review of OUHSC Legal office and IRB. Data sharing agreement required. Contact research@ouhsc.edu to initiate data requests. No personally identifiable data will be shared.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |